ABT-869 is a small molecule ATP-competitive inhibitor that potently targets VEGF and PDGF receptor tyrosine kinases. Its active hydrophilic metabolite, A-849529, facilitates research into angiogenesis and tumor growth in both cellular assays and animal models.
Molecular Weight:
405.38
CAS Number:
[819058-88-3]
Formula:
C21H16FN5O3
Target:
Drug Metabolite
* VAT and and shipping costs not included. Errors and price changes excepted
